{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:58:10Z","timestamp":1760731090459},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research","award":["15H04900","26117003"],"award-info":[{"award-number":["15H04900","26117003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12883-018-1115-3","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T02:47:43Z","timestamp":1533696463000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["[18F]THK-5351 PET imaging in early-stage semantic variant primary progressive aphasia: a report of two cases and a literature review"],"prefix":"10.1186","volume":"18","author":[{"given":"Ryota","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Kawakatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Ishiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Otani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"1115_CR1","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006\u201314.","journal-title":"Neurology"},{"key":"1115_CR2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/jnnp-2013-306948","volume":"85","author":"L Chare","year":"2014","unstructured":"Chare L, Hodges JR, Leyton CE, McGinley C, Tan RH, Kril JJ, et al. New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications. J Neurol Neurosurg Psychiatry. 2014;85:865\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1115_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2967\/jnumed.115.164848","volume":"57","author":"R Harada","year":"2016","unstructured":"Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, et al. 18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease. J Nucl Med. 2016;57:208\u201314.","journal-title":"J Nucl Med"},{"key":"1115_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/ene.13164","volume":"24","author":"A Ishiki","year":"2017","unstructured":"Ishiki A, Harada R, Okamura N, Tomita N, Rowe CC, Villemagne VL, et al. Tau imaging with [18F]THK-5351 in progressive supranuclear palsy. Eur J Neurol. 2017;24:130\u20136.","journal-title":"Eur J Neurol"},{"key":"1115_CR5","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1212\/WNL.0000000000003375","volume":"87","author":"A Kikuchi","year":"2016","unstructured":"Kikuchi A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, et al. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET. Neurology. 2016;87:2309\u201316.","journal-title":"Neurology"},{"key":"1115_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2967\/jnumed.117.197426","volume":"59","author":"R Harada","year":"2018","unstructured":"Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, et al. Correlations of 18F-THK5351 PET with post-mortem burden of tau and astrogliosis in Alzheimer's disease. J Nucl Med. 2018;59:671\u20134.","journal-title":"J Nucl Med"},{"key":"1115_CR7","first-page":"1","volume":"8","author":"M Takaya","year":"2017","unstructured":"Takaya M, Ishii K, Hosokawa C, Saigoh K, Shirakawa O. Tau accumulation in two patients with frontotemporal lobe degeneration showing different types of aphasia using 18F-THK-5351 positron emission tomography: a case report. Int Psychogeriatr. 2017;8:1\u20136.","journal-title":"Int Psychogeriatr"},{"key":"1115_CR8","doi-asserted-by":"publisher","unstructured":"Lee H, Seo S, Lee SY, Jeong HJ, Woo SH, Lee KM, et al. [18F]-THK5351 PET imaging in patients with semantic variant primary progressive aphasia. Alzheimer Dis Assoc Disord. 2017; \n                    https:\/\/doi.org\/10.1097\/WAD.0000000000000216\n                    \n                  .","DOI":"10.1097\/WAD.0000000000000216"},{"key":"1115_CR9","doi-asserted-by":"publisher","unstructured":"Jang YK, Lyoo CH, Park S, Oh SJ, Cho H, Oh M, et al. Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia. Eur J Nucl Med Mol Imaging. 2017; \n                    https:\/\/doi.org\/10.1007\/s00259-017-3876-0\n                    \n                  .","DOI":"10.1007\/s00259-017-3876-0"},{"key":"1115_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/cns.12509","volume":"22","author":"JX Hou","year":"2016","unstructured":"Hou JX, Cheng SS, Chen L, Wang QH, Shi Y, Xu Y, et al. Astroglial activation and tau hyperphosphorylation precede to neuron loss in a neurodegenerative mouse model. CNS Neurosci Ther. 2016;22:244\u20137.","journal-title":"CNS Neurosci Ther"},{"key":"1115_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s00259-016-3591-2","volume":"44","author":"T Yamane","year":"2017","unstructured":"Yamane T, Ishii K, Sakata M, Ikari Y, Nishio T, Ishii K, et al. Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multicenter study. Eur J Nucl Med Mol Imaging. 2017;44:850\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1115_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MNM.0b013e328013eb8b","volume":"28","author":"H Matsuda","year":"2007","unstructured":"Matsuda H, Mizumura S, Nagao T, Ota T, Iizuka T, Nemoto K, et al. An easy Z-score imaging system for discrimination between very early Alzheimer's disease and controls using brain perfusion SPECT in a multicentre study. Nucl Med Commun. 2007;28:199\u2013205.","journal-title":"Nucl Med Commun"},{"key":"1115_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.arr.2016.01.003","volume":"30","author":"H Matsuda","year":"2016","unstructured":"Matsuda H. MRI morphometry in Alzheimer\u2019s disease. Ageing Res Rev. 2016;30:17\u201324.","journal-title":"Ageing Res Rev"},{"key":"1115_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ana.24885","volume":"81","author":"EG Spinelli","year":"2017","unstructured":"Spinelli EG, Mandelli ML, Miller ZA, Santos-Santos MA, Wilson SM, Agosta F, et al. Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol. 2017;81:430\u201343.","journal-title":"Ann Neurol"},{"key":"1115_CR15","doi-asserted-by":"crossref","unstructured":"Harada R, Okamura N, Furumoto S, Ishiki A, Furukawa K, Tomita N, et al. Validation of the binding specificity of tau PET tracer [18F]THK-5351 on postmortem human brain samples. Poster session presented at: the Alzheimer\u2019s Association International Conference 2015; July 18\u201323, 2015; Washington, DC.","DOI":"10.1016\/j.jalz.2015.07.354"},{"key":"1115_CR16","doi-asserted-by":"publisher","unstructured":"Ng KP, Pascoal TA, Mathotaarachchi S, Therriault J, Kang MS, Shin M, et al. Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain. Alzheimers Res Ther. 2017; \n                    https:\/\/doi.org\/10.1186\/s13195-017-0253-y\n                    \n                  .","DOI":"10.1186\/s13195-017-0253-y"},{"key":"1115_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/brain\/awv387","volume":"139","author":"F Kumfor","year":"2016","unstructured":"Kumfor F, Landin-Romero R, Devenney E, Hutchings R, Grasso R, Hodges JR, et al. On the right side? A longitudinal study of left- versus right-lateralized semantic dementia. Brain. 2016;139:986\u201398.","journal-title":"Brain"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-018-1115-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:07:00Z","timestamp":1565204820000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-018-1115-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1186\/s12883-018-1115-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]},"assertion":[{"value":"22 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Yamagata University School of Medicine and Tohoku University School of Medicine. Written informed consent was obtained from the patients for participation in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication of anonymized case details was obtained from the patients and the patient\u2019s spouses. A copy of the written consent is available for review by the Editor of this Journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have read and understood BMC policy on declaration of interests and declare the following interests: Dr. Okamura is a consultant for Clino Corp (Sendai, Japan).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"109"}}